{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:13:45Z","timestamp":1783628025425,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.placenta.2020.01.007","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T02:25:02Z","timestamp":1579746302000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Biomarkers of abnormally invasive placenta"],"prefix":"10.1016","volume":"91","author":[{"given":"A.","family":"Al-Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.H.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.P.","family":"Illsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Remache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Alvarez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mannion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zamudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.placenta.2020.01.007_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"10","key":"10.1016\/j.placenta.2020.01.007_bib2","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1210\/en.2007-0286","article-title":"Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma","volume":"148","author":"Handschuh","year":"2007","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.placenta.2020.01.007_bib3","doi-asserted-by":"crossref","first-page":"E240","DOI":"10.1210\/jc.2010-0138","article-title":"Hyperglycosylated hCG is a marker of early human trophoblast invasion","volume":"95","author":"Guibourdenche","year":"2010","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.placenta.2020.01.007_bib4","doi-asserted-by":"crossref","first-page":"201629","DOI":"10.1155\/2015\/201629","article-title":"Decorin-mediated inhibition of human trophoblast cells proliferation, migration, and invasion and promotion of apoptosis in vitro","volume":"2015","author":"Zou","year":"2015","journal-title":"BioMed. Res. Int."},{"issue":"3","key":"10.1016\/j.placenta.2020.01.007_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/aji.12449","article-title":"Restraint of trophoblast invasion of the uterus by decorin: role in pre-eclampsia","volume":"75","author":"Nandi","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.placenta.2020.01.007_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.03.020","article-title":"Decorin over-expression by decidual cells in preeclampsia: a potential blood biomarker","volume":"215","author":"Siddiqui","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2020.01.007_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/his.12304","article-title":"Decorin and biglycan immunolocalization in non-villous structures of healthy and pathological human placentas","volume":"64","author":"Borbely","year":"2014","journal-title":"Histopathology"},{"issue":"21","key":"10.1016\/j.placenta.2020.01.007_bib8","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Canc. Res."},{"issue":"12","key":"10.1016\/j.placenta.2020.01.007_bib9","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.placenta.2015.10.013","article-title":"Differentiation of first trimester cytotrophoblast to extravillous trophoblast involves an epithelial-mesenchymal transition","volume":"36","author":"DaSilva-Arnold","year":"2015","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.placenta.2020.01.007_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/biolre\/ioy042","article-title":"Human trophoblast epithelial-mesenchymal transition in abnormally invasive placenta","volume":"99","author":"DaSilva-Arnold","year":"2018","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.placenta.2020.01.007_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/REP-09-0341","article-title":"Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1","volume":"139","author":"Jovanovic","year":"2010","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.placenta.2020.01.007_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0038-1636501","article-title":"Hyperglycosylated hCG and placenta accreta spectrum","volume":"36","author":"Einerson","year":"2019","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.placenta.2020.01.007_bib13","doi-asserted-by":"crossref","first-page":"1507674","DOI":"10.1155\/2018\/1507674","article-title":"Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers","volume":"2018","author":"Bartels","year":"2018","journal-title":"Dis. Markers"},{"issue":"9","key":"10.1016\/j.placenta.2020.01.007_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/pd.2056","article-title":"Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy","volume":"28","author":"Miura","year":"2008","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.placenta.2020.01.007_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijgo.2009.11.013","article-title":"Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta","volume":"109","author":"El Behery","year":"2010","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"2","key":"10.1016\/j.placenta.2020.01.007_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1933719113492209","article-title":"Increased levels of cell-free human placental lactogen mRNA at 28-32 gestational weeks in plasma of pregnant women with placenta previa and invasive placenta","volume":"21","author":"Kawashima","year":"2014","journal-title":"Reprod. Sci."},{"issue":"9","key":"10.1016\/j.placenta.2020.01.007_bib17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.placenta.2014.07.007","article-title":"Maternal plasma levels of cell-free beta-HCG mRNA as a prenatal diagnostic indicator of placenta accreta","volume":"35","author":"Zhou","year":"2014","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.placenta.2020.01.007_bib18","first-page":"197","article-title":"Portal vein and superior mesenteric vein thrombosis after cesarean hysterectomy","volume":"19","author":"Naghshineh","year":"2014","journal-title":"J. Res. Med. Sci."},{"issue":"4","key":"10.1016\/j.placenta.2020.01.007_bib19","first-page":"693","article-title":"Placenta accreta\/percreta\/increta: a cause of elevated maternal serum alpha-fetoprotein","volume":"80","author":"Zelop","year":"1992","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2020.01.007_bib20","first-page":"266","article-title":"Placenta accreta is associated with elevated maternal serum alpha-fetoprotein","volume":"82","author":"Kupferminc","year":"1993","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2020.01.007_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/pd.4277","article-title":"Elevated first trimester PAPP-A is associated with increased risk of placenta accreta","volume":"34","author":"Desai","year":"2014","journal-title":"Prenat. Diagn."},{"issue":"10","key":"10.1016\/j.placenta.2020.01.007_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/pd.3932","article-title":"Second-trimester maternal serum markers and placenta accreta","volume":"32","author":"Dreux","year":"2012","journal-title":"Prenat. Diagn."},{"issue":"10","key":"10.1016\/j.placenta.2020.01.007_bib23","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/1471-0528.13298","article-title":"First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation","volume":"122","author":"Thompson","year":"2015","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.placenta.2020.01.007_bib24","first-page":"35","article-title":"Association between maternal serum alpha-fetoprotein and adverse outcomes in pregnancies with placenta previa","volume":"97","author":"Butler","year":"2001","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.placenta.2020.01.007_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.12.027","article-title":"Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast","volume":"204","author":"Wehrum","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"19","key":"10.1016\/j.placenta.2020.01.007_bib26","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.3109\/14767058.2015.1118044","article-title":"Serum angiogenic profile in abnormal placentation","volume":"29","author":"Biberoglu","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"4","key":"10.1016\/j.placenta.2020.01.007_bib27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0002-9378(99)70683-6","article-title":"Creatine kinase as a biochemical marker in diagnosis of placenta increta and percreta","volume":"180","author":"Ophir","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"24","key":"10.1016\/j.placenta.2020.01.007_bib28","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.3109\/14767058.2016.1152576","article-title":"Can venous ProBNP levels predict placenta accreta?","volume":"29","author":"Ersoy","year":"2016","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.placenta.2020.01.007_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.01.004","article-title":"Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta","volume":"39","author":"Oztas","year":"2016","journal-title":"Placenta"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400420300175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400420300175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:00:26Z","timestamp":1758909626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400420300175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"alternative-id":["S0143400420300175"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2020.01.007","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of abnormally invasive placenta","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2020.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}